Glimepiride
Product Images NDC 60760-248

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 60760-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary�s Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glimepiride 60760 248 90

Glimepiride Tablets USP 4 mg label displaying drug name, strength, dosage form, and quantity (90 tablets). Manufactured by Intas Pharmaceuticals Limited, India, and packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. Includes directions to use as directed and storage instructions for controlled room temperature (15°-30°C). Contains NDC 60760-248-90 with placeholder text for lot number and expiration.*

FDA Label Image

Structure (Glimepiride Structure)

Chemical structure diagram of Glimepiride, showing its molecular composition including multiple ring structures, functional groups such as sulfonyl, amide, and ketone groups, and connected side chains characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.